FDA 510(k) Exemption for Clinical Toxicology Devices: What IVD Makers Need to Know

Podcast: Medical Device Global Market Access · Pure Global

Opublikowano: 2026-10-13

The US FDA issued a final order on October 5, 2026, exempting certain Class II clinical toxicology test systems from 510(k) premarket notification requirements. This episode breaks down the immediate impact for IVD manufacturers, detailing which specific device types are affected, the critical limitations to the exemption, and the ongoing compliance obligations under general controls, such as the Quality System Regulation. We explore how this change affects market access strategies and provide actionable steps for regulatory and quality teams. Key Questions: - Which specific clinical toxicology devices are now exempt from FDA 510(k) requirements as of October 6, 2026? - What are the critical...